Recurrent Prostate Cancer

Written by

Prof Nat Lenzo Dr Tee Lim

Recurrent Prostate Cancer

Contrary to declining death rates for many common cancers, prostate cancer deaths are rising, with an increase of 5 percent from 2019 to 2020.1 Although most primary prostate cancer cases can be managed with radiotherapy or radical prostatectomy, 40 percent of men treated for this cancer will have disease relapse,2 with castration-resistant prostate cancer accounting for most deaths.3 68Ga PSMA-11 PET/CT suggests better sensitivity to low levels of PSA,4 and the ability to identify the location of disease recurrence after radical prostatectomy in half of the patients with a PSA level between 0.5 and 1 ng/ml,5,6 as demonstrated in this case study.

Download